Reducing glypican-4 in ES cells improves recovery in a rat model of Parkinson's disease by increasing the production of dopaminergic neurons and decreasing teratoma formation. [electronic resource]
Producer: 20140804Description: 8318-23 p. digitalISSN:- 1529-2401
- Animals
- Calbindins -- metabolism
- Cell Count
- Cell Differentiation
- Disease Models, Animal
- Dopamine Plasma Membrane Transport Proteins -- metabolism
- Dopaminergic Neurons -- physiology
- Embryonic Stem Cells -- transplantation
- Glypicans -- genetics
- Green Fluorescent Proteins -- genetics
- Hepatocyte Nuclear Factor 3-beta -- metabolism
- Humans
- Mice
- Motor Activity -- drug effects
- Parkinson Disease -- physiopathology
- Rats
- Receptors, Dopamine D2 -- metabolism
- Recovery of Function -- physiology
- Teratoma -- etiology
- Tyrosine 3-Monooxygenase -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.